Cystic fibrosis and inflammation;Inflammation et mucoviscidose

Archives de Pediatrie

Volumn 10, Issue SUPPL. 2, 2003, Pages

  Delacourt, C ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Cystic fibrosis; Inflammation

Indexed keywords

AUTACOID; PROTEINASE; REACTIVE OXYGEN METABOLITE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CELL FUNCTION; CELL TYPE; CONFERENCE PAPER; CYSTIC FIBROSIS; DISEASE SEVERITY; ENZYME ACTIVITY; GENE LOCUS; HEREDITY; HOST RESISTANCE; HUMAN; LUNG INFECTION; MEDIATOR RELEASE; NEUTROPHIL; PATHOPHYSIOLOGY; PNEUMONIA; RESPIRATORY TRACT DISEASE;

EID: 0042876788     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(03)90630-0     Document Type: Conference Paper

References (31)

1. Nakamura H, Yoshimura K, McElvaney NG, Crystal RG. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest 1992; 89: 1478-84.
2. Ciabattoni G, Davi G, Collura M, Iapichino L, Pardo F, Ganci A, et al. In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med 2000; 162: 1195-201.
3. Murphy G, Reynolds JJ. Extracellular matrix degradation. In: Royce PM, Steinmann B, éd. Connective tissue and its heritable disorders. New York: Wiley-Liss, Inc; 1993. p 287-316.
4. Rao NV, Marshall BC, Gray BH, Hoidal JR. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am J Respir Cell Mol Biol 1993; 8: 612-6.
5. Meyer KC, Lewandoski JR, Zimmerman JJ, Nunley D, Calhoun WJ, Dopico GA. Human neutrophil elastase and elastase/a1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy. Am Rev Respir Dis 1991; 144: 580-5.
6. Bruce MC, Poncz L, Klinger JD, Stern RC, Tomashefski JF Jr, Dearborn DG. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis 1985; 132: 529-35.
7. Delacourt C, Le Bourgeois M, d'Ortho MP, Doit C, Scheinmann P, Navarro J, et al. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 1995; 152: 765-74.
8. Ferry G, Lonchampt M, Pennel L, de Nanteuil G, Canet E, Tucker GC. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett 1997; 402: 111-5.
9. Itoh Y, Nagase H. Preferential inactivation of tissue inhibitor of metalloproteinases 1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem 1995; 270: 16518-21.
10. Peterson MW, Walter ME, Nygaard SD. Effect of neutrophil mediators on epithelial permeability. Am J Respir Cell Mol Biol 1995; 13: 719-27.
11. Canonico AE, Brigham KL, Carmichael LC, Plitman JD, King GA, Blackwell TR, et al. Plasmid-liposome transfer of the a1 antitrypsin gene to cystic fibrosis bronchial epithelial cells prevents elastase-induced cell detachment and cytokine release. Am J Respir Cell Mol Biol 1996; 14: 348-55.
12. Schuster A, Fahy JV, Ueki I, Nadel JA. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors. Eur Respir J 1995; 8: 10-4.
13. Doring G, Dauner HM. Clearance of Pseudomonas aeruginosa in different rat lung models. Am Rev Respir Dis 1988; 138: 1249-53.
14. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997; 156: 1197-204.
15. Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995; 20: 63-70.
16. Dakin CJ, Numa AH, Wang H, Morton JR, Vertzyas CC, Henry RL. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 2002, 165: 904-10.
17. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151: 1075-82.
18. Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999; 160: 186-91.
19. Zahm JM, Gaillard D, Dupuit F, Hinnrasky J, Porteous D, Dorin JR, et al. Early alterations in airway mucociliary clearance and inflammation of the lamina propria in cystic fibrosis mice. Am J Physiol 1997; 272: C853-9.
20. Tabary O, Zahm JM, Hinnrasky J, Couetil JP, Cornillet P, Guenounou M, et al. Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 1998; 153: 921-30.
21. Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995; 13: 257-61.
22. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111-8.
23. Chmiel JF, Konstan MW, Saadane A, Krenicky JE, Lester Kirchner H, Berger M. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. Am J Respir Crit Care Med 2002; 165: 1176-81.
24. Tirouvanziam R, de Bentzmann S, Hubeau C, Hinnrasky J, Jacquot J, Peault B, et al. Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 2000; 23: 121-7.
25. Muhlebach MS, Noah TL. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am J Respir Crit Care Med 2002; 165: 911-5.
26. Coakley RJ, Taggart C, Canny G, Greally P, O'Neill SJ, McElvaney MG. Altered intracellular pH regulation in neutrophils from patients with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2000; 279: L66-74.
27. Scheid P, Kempster L, Griesenbach U, Davies JC, Dewar A, Weber PP, et al. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J 2001; 17: 27-35.
28. Pressler T, Pandey JP, Espersen F, Pedersen SS, Fomsgaard A, Koch C, et al. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. Clin Exp Immunol 1992; 90: 209-14.
29. Hull J, Thomson AH. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 1998; 53: 1018-21.
30. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, et al. TGF-bet (1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 2000; 55: 459-62.
31. Gabolde M, Guilloud-Bataille M, Feingold J, Besmond C. Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study. BMJ 1999; 319: 1166-7.